tiprankstipranks
Trending News
More News >
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
US Market

FibroBiologics, Inc. (FBLG) Financial Statements

Compare
237 Followers

FibroBiologics, Inc. Financial Overview

FibroBiologics, Inc.'s market cap is currently $22.21M. The company's EPS TTM is $; its P/E ratio is -0.75; FibroBiologics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -832.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -16.65M$ -13.74M$ -8.89M$ -4.47M$ -1.58M
EBITDA$ -17.61M$ -10.57M$ -15.90M$ -4.37M$ -1.58M
Net Income$ -18.65M$ -11.16M$ -16.48M$ -5.12M$ -1.58M
Balance Sheet
Cash & Short-Term Investments$ 4.89M$ 13.98M$ 9.16M$ 2.27M$ 407.00K
Total Assets$ 9.62M$ 16.45M$ 11.82M$ 4.82M$ 468.00K
Total Debt$ 2.41M$ 10.55M$ 1.75M$ 7.52M$ 1.30M
Net Debt$ -2.48M$ -3.43M$ -7.42M$ 5.26M$ 893.00K
Total Liabilities$ 3.46M$ 13.71M$ 10.57M$ 8.82M$ 1.76M
Stockholders' Equity$ 6.16M$ 2.73M$ 1.25M$ -4.00M$ -1.29M
Cash Flow
Free Cash Flow$ -16.66M$ -12.09M$ -6.90M$ -4.07M$ -1.41M
Operating Cash Flow$ -16.39M$ -11.90M$ -6.40M$ -4.07M$ -1.41M
Investing Cash Flow$ -262.00K$ -184.00K$ -495.00K$ 0.00$ 0.00
Financing Cash Flow$ 7.57M$ 16.91M$ 13.79M$ 5.92M$ 1.82M
Currency in USD

FibroBiologics, Inc. Earnings and Revenue History

FibroBiologics, Inc. Debt to Assets

FibroBiologics, Inc. Cash Flow

FibroBiologics, Inc. Forecast EPS vs Actual EPS